CN Patent

CN111278808B — 2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-n-苄基乙酰胺的固体形式

Assigned to Anzix Special Purpose Co ltd · Expires 2024-04-26 · 2y expired

What this patent protects

本申请提供2‑(5‑(4‑(2‑吗啉代乙氧基)苯基)吡啶‑2‑基)‑N‑苄基乙酰胺的固体形式，及其制备和使用方法。

USPTO Abstract

本申请提供2‑(5‑(4‑(2‑吗啉代乙氧基)苯基)吡啶‑2‑基)‑N‑苄基乙酰胺的固体形式，及其制备和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN111278808B
Jurisdiction
CN
Classification
—
Expires
2024-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Anzix Special Purpose Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.